Navigation Links
Forecast Looks Good for India Pharma Shows
Date:11/9/2009

ences complementing the exhibitions. These begin with the Indian Pharma Summit on Monday 30 November, focusing on: "The future of India Pharma - India Pharma Vision 2020" addressing the issues, opportunities and challenges for India as an emerging global pharma hub.

The event will be chaired by Ashok Kumar, Secty. Dept. of Pharmaceuticals and co-chaired by Glenn Saldhana, Chairman, FICCI National Pharmaceuticals Committee & MD and CEO, Glenmark Pharmaceuticals. Organisers are the Government of India's new Department of Pharmaceuticals and UBM India Pvt. Ltd. Venue is the Mumbai Grand Hyatt.

Staged alongside the first two days of CPhI India, in the BioPh pavilion at the Bombay Exhibition Centre, Biosimilars India 2009 will cover a wide range of topics in 17 sessions across three half-day modules.

"India is now moving towards centrestage in world pharma, with its overall pharma market growing at better than 9% - and key segments much faster. CPhI and the co-located events are the natural meeting point that enables a high level of networking and business development across the academic, development, R&D, services and manufacturing communities", said CPhI India Event Director Annemieke Timmers.

"With the BioPh India and ICSE India launches and a strong conference programme adding to a high level of pre-registrations, all our indications are that this year in Mumbai will see our strongest Indian events so far", added ICSE, BioPh and P-MEC Event Director Haf Cennydd.

Key industry organisations supporting the exhibitions will include Pharmexcil - the Government of India's pharmaceutical export promotion council; the Indian Drug Manufacturers Association (IDMA); the Organisation of Pharmaceutical Producers of India (OPPI) and the Bulk Drug Manufacturers Association (India) (BDMA).

The events are jointly organised by U
'/>"/>

SOURCE CPhI India
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
2. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
3. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
4. Reportlinker Adds Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015
5. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
6. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
7. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
8. ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India
9. International Diabetes Federation Grant Supports Lifestyle Intervention Study to Prevent Type 2 Diabetes in India
10. Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks
11. Patient Recruitment Begins in India for Phase 3 Diabetes Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bul...ich develops, licenses, manufactures, distributes ...ed its operating results for the first quarter end...cluding royalty income, were $1,683,673 in the FY2...ted in the previous year first quarter (FY2009). ...
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Landauer, Inc. ( LDR)...fourth quarter and full year of 2009 pre-market on... host a conference call for investors on Tuesday, ...tors may access the live call by dialing 877-941-9...629-9835 (international callers), or by visiting t...
(Date:11/20/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue. ,, Blood Pressure Monitoring & Measu..., http://www.reportlinker.com/p0164309/Blood-Pre...d-Market-Analysis.html#utm_source=prnewswire&u...easurement of blood pressure is not only an indica...
Breaking Medicine Technology:Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 3Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 4Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 5Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 6Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 7Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 8Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 9Scientists discover key factor in regulating placenta and fetal growth 9988 1Scientists discover key factor in regulating placenta and fetal growth 9988 2Paralyzed Rats Walk Again 57714 1Paralyzed Rats Walk Again 57714 2Paralyzed Rats Walk Again 57714 3Traditional Chinese Medicine and Acupuncture Continue to Grow in Popularity Due to Focus on Natural Health 57713 1Traditional Chinese Medicine and Acupuncture Continue to Grow in Popularity Due to Focus on Natural Health 57713 2
... New Progression-Free Survival, Disease Control an...Annual Meeting Continue to Support Picoplatin as a... First-Line Treatment of Colorectal Cancer - , , ...stor Briefing to Discuss Data on Sunday, May 31st ...rd Pharmaceuticals, Inc. (Nasdaq: PARD ), a biop...
...- Oral presentation on Sandostatin(R) LAR Depot Ph...n patients with advanced neuroendocrine tumors of ...weeks of treatment, Afinitor(R) stabilized or redu...ver cancer , , - New data reveal postmenopausal...nce better cognitive function than those taking ta...
Other Medicine Technology:Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 2Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 3Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 4Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 5Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 6Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 2Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 3Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 4Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 5Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 6Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 7Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 8Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 9Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 10Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 11Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 12Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 13Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 14Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 15Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 16Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 17Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types 18
(Date:11/20/2009)..., , WASHINGTON, Nov. 20 /PRNewswire-USN...ic Bishops urged the Senate to make essential chan...ce federal law on abortion funding and conscience ...are for immigrants and include strong provisions f...d the Senate health care bill an "enormous disappo...
(Date:11/20/2009)..., , CHICAGO, Nov. 20 /PRNewswire-USNewswire/...ked the U.S. Food and Drug Administration (FDA) to...hitening chemicals. ,, Citing concern about th...nistered without the benefit of professional consu...on said that the application of chemically based t...
(Date:11/20/2009)..., , LAS VEGAS, Nov. 20 /PRNewswire-USNewswire..., Executive Director of the Nevada Health Care Ass...n (NHCA) commends and thanks Senate Majority Leade...on a step closer toward our goal of protecting eve...ng home care, and preserving the strength and viab...
(Date:11/20/2009)... Spot blood pressure readings in children with chr...ion even during doctor,s office visits increasin...ding to research from Johns Hopkins Children,s Cen...gs appears online in the Journal of American Socie... pressure measurements obtained during regular doc...
(Date:11/20/2009)...onsumers save up to one-third buying 90-day supply...hDay News) -- Buying a three-month supply of presc...ng a one-month supply, according to a new study. ,... filled for 395 drugs between 2000 and 2005, and f... instead of a one-month supply saved an average 29...
Breaking Medicine News(10 mins):Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:High blood pressure easy to miss in children with kidney disease 2Health News:Three-Month Supply Lowers Drug Costs 2
... orientation , THURSDAY, Oct. 25 (HealthDay News) ... of small worms called nematodes, say scientists w...o make them attracted to the same sex. , The findi...attraction behaviors are derived from the same bra...
...ocus of the Staying Sharp session on November 3 at...n San Diego. Part of a highly recognized series, ...ding how to deal with the booming aging industry; ...ed by The Dana Alliance for Brain Initiatives, in ...
...olunteerism and,Humanitarianism, ATLANTA, Oct. 25...on have helped reduce the burden of cancer today,r...r Society for their work,in cancer control, volunt...ing to make the Society,s mission of,eliminating c...
...zing than sit-down meals, COLUMBUS, Ohio, Oct. 25...devices such as laptops, mobile phones and MP3,pla...de. According to a,recent survey(1) conducted for ...order to multitask and spend more time using,perso...
...nse, scientists say , THURSDAY, Oct. 25 (HealthDay...the molecular structure of a cellular receptor tha..., The beta 2-adrenergic receptor is one of many G ...versity School of Medicine, Calif. , Reporting Oct...
...ects Cancer Prevention Expert and First Hispanic ...and Health Communications Expert Marion E. Morra t.... 25 - The American Cancer,Society, the nation,s l...is week in Atlanta. The organization,s National,As...
Other Medicine News:Health News:Worm Study Points to Sexuality's Origins 2Health News:American Cancer Society Honors Outstanding Contributions to Fight Against Cancer 2Health News:American Cancer Society Honors Outstanding Contributions to Fight Against Cancer 3Health News:American Cancer Society Honors Outstanding Contributions to Fight Against Cancer 4Health News:ZonePerfect(R) Survey Finds Americans Are Overfed on Technology, Underfed at the Dinner Table 2Health News:ZonePerfect(R) Survey Finds Americans Are Overfed on Technology, Underfed at the Dinner Table 3Health News:New Volunteers Selected to Lead American Cancer Society 2Health News:New Volunteers Selected to Lead American Cancer Society 3Health News:New Volunteers Selected to Lead American Cancer Society 4Health News:New Volunteers Selected to Lead American Cancer Society 5Health News:New Volunteers Selected to Lead American Cancer Society 6
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: